![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > France
Please find below persons from France.Total search results: 1294 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Nguyen, Evelyne (Biophytis 202101 CFO) | Chief Financial Officer (CFO) | Biophytis (Group) | Île-de-France (region) |
| Nguyen, Laurent (Accure Therapeutics 202005– CEO before Sensorion 201701 CEO) | Chief Executive Officer (CEO) | Accure Therapeutics (ES) | Catalonia |
| Nicolas, Leila (Go Capital (FR) 201801 Investment Director) | Investment Manager | GO Capital (FR) | Bretagne (Britanny) (region) |
| Nicolas, Marie-Amélie (Atlantic Bone Screen 201407 Business Development Manager at Atlanchim Pharma Sarl) | Business Development Manager / Strategy Manager | Atlantic Bone Screen (Group) | France (region/state unspecified) |
| Nicoud, Roger-Marc (Novasep 201210–201302 Non-executive Chairman before CEO + founder) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
| Nobécourt, Gilles (LCF Rothschild 201105 Partner at EdRIP) | Partner (venture partner) | Andera Partners (FR) | Île-de-France (region) |
| Noblet, Kevin (Taddeo 202102) | Public Relations Manager / Investor Relations Manager | Taddeo SAS | Île-de-France (region) |
| Nonhoff, Offer (Pixium Vision 202106– CFO before Trigo + Lumenis + BoneSupport + Fresenius Medical Care Israel) | Chief Financial Officer (CFO) | Pixium Vision S.A. | Île-de-France (region) |
| Nothias, Jean-Yves (Amundi 201107 Managing Partner Life Sciences before Société Générale Managing Director Biotech VC) | Managing Partner (investment firm) | Amundi (Group) | Île-de-France (region) |
| Nour, Afif Abdel (Stilla Technologies 202402– VP of Global Marketing before Qiagen + Bio-Rad) | Sales Manager / Marketing Manager | Stilla Technologies (Group) | Île-de-France (region) |
| Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) | Board member, non-executive | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Núnez-Garcia, Sara (Forty51 Advisors 202204– Partner + Co-Founder formerly Sofinnova Partners 201410 Associate) | Partner (venture partner) | Forty51 Ventures (Group) | Northwestern Switzerland (region) |
| Obenshain, Andrew (Bluebird Bio 201612– Head of Europe before Shire in Paris + Sanofi + Genzyme) | Regional manager | Bluebird Bio (Group) | Île-de-France (region) |
| Oelrich, Stefan (Bayer 201811– Head of Pharma division before Sanofi Head of Diabetes + Cardiovascular) | President/Director/Head Business Group/Unit/Division | Bayer (Group) | Germany (state/region unspecified) |
| Oestreich, Stephanie (Mnemo Therapeutics 202106 VP of Operations + Head of Alliance Management) | Chief Operating Officer (COO) | Mnemo Therapeutics (FR) | Île-de-France (region) |
| Oger, Jean-Louis (Bio-Access 201506 CEO + Founder) | Chief Executive Officer (CEO) | Eurofins (Group) | France (region/state unspecified) |
| Oldfield, Steve (Teva 201506– General Manager UK +IE before Sanofi Managing Director UK+IE) | General Manager (management) | Teva (Group) | |
| Olive, Daniel (Institut Paoli-Calmettes 201705 Professor) | Professor | Unicancer (Group) | Provence-Alpes-Côte d’Azur (region) |
| Orešanský, Dušan (NewCap 201404) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Osdoit, Anne (Sofinnova 202107 Partner at Sofinnova MD Start Fund) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Oussaifi, Yassine (Cathay Capital 202109 Partner at Cathay AfricInvest) | Partner (venture partner) | Cathay Capital (Group) | Île-de-France (region) |
| Ouzren, Nawal (Sensorion 201905 CEO) | Chief Executive Officer (CEO) | Sensorion S.A. (Euronext Alternext: ALSEN) | Occitanie (Occitania) (region) |
| O’Neill, Julie (Hookipa 201811– non-exec Board Member as well as at DBV Technologies before Alexion + Gilead) | Board member, non-executive | Hookipa (Group) | New York (federal state) |
| Pagès, Diane-Laure (Orakl Oncology 202310 COO + Co-Founder) | Chief Operating Officer (COO) | Orakl Oncology SAS | Île-de-France (region) |
| Palge, Fabienne (F-DGSi 201408 Global Business Development Manager) | Business Development Manager / Strategy Manager | F-DGSi (FR) | Île-de-France (region) |
| Palmantier, Rémi (Genticel 201601– CSO before GSK Vaccines + GSK Biologics) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
| Pando, Matt (ExonHit 200801 appointed Head of new Therapeutics Unit) | n. a. | Eurobio Scientific (Group) | Île-de-France (region) |
| Pannier-Runacher, Agnès (France (govt) 202107 Minister Delegate for Industry) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
| Paoli, Xavier (Pharnext 201709 CCO) | Chief Commercial Officer (CCO) | Pharnext S.A. (Euronext Paris: ALPHA) | Île-de-France (region) |
| Paolini, John F. (Cerenis 201111– CMO before Bayer Healthcare Pharmaceuticals + Merck & Co Inc) | Chief Medical Officer (CMO) | Abionyx (Group) | Occitanie (Occitania) (region) |
| Papatheodorou, Elias (Genkyotex 201707 before Covagen + Medigene + Novosom + A.T.I. + Coca-Cola + Philip Morris) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
| Paper, Thierry (Biosynex 201509 General Manager) | General Manager (management) | Biosynex S.A. | Grand Est (Great East) (region) |
| Papiernik, Antoine (Sofinnova Partners 201703 Managing Partner + Chairman joined 1997) | Managing Partner (investment firm) | Sofinnova (Group) | Île-de-France (region) |
| Papot, Sébastian (Univ Poitiers 202001 Prof + Seekyo 201806– CSO + Co-Founder) | Professor | University of Poitiers | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Pâques, Frédéric (Global Bioenergies 201702 COO) | Chief Operating Officer (COO) | Global Bioenergies (Group) | Île-de-France (region) |
| Paqueville, Frédéric (Excelya 202010 Executive President + Co-Founder) | President/Director/Head Business Group/Unit/Division | Excelya (Group) | Île-de-France (region) |
| Parisot, Jean-Yves (Symrise 202403– CEO joined 2014 before Diana Group + Air Liquide + Danisco) | Chief Executive Officer (CEO) | Symrise (Group) | Niedersachsen (federal state) |
| Parker, Andrew (Step Pharma 201909– CEO before Zealand Pharma + Eclosion2 + AstraZeneca + JnJ + Opsana Therapeutics) | Chief Executive Officer (CEO) | Step Pharma SAS | Auvergne-Rhône-Alpes (region) |
| Parmentier, Bertrand (Pierre Fabre 201602–201806 Group CEO RETIRED 6/18) | Chief Executive Officer (CEO) | Pierre Fabre (Group) | Île-de-France (region) |
| Paronneau, Anthony (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
| Pasquero, Gwenaëlle (Scipio Bioscience 202206 Director of Marketing/Sales) | Sales Manager / Marketing Manager | Scipio Bioscience SAS | Île-de-France (region) |
| Pasquier, Olivier (Prestodiag 201405 VP Sales + Marketing before Abaxxi + Cytoo + Qiagen) | Sales Manager / Marketing Manager | Prestodiag SAS | Île-de-France (region) |
| Passioukov, Alexandre (Pierre Fabre 201805 VP Translational Medicine at IRPF) | n. a. | Pierre Fabre (Group) | Occitanie (Occitania) (region) |
| Passy, Pierre-Michel (LCF Rothschild 201311 CEO of EdRIP) | Investment Manager | Andera Partners (FR) | Île-de-France (region) |
| Pasternak, Richard (Abionyx 201909– Board Chairman before CEO of predecessor Cerenis) | Board member, non-executive | Abionyx (Group) | Occitanie (Occitania) (region) |
| Patel, Dipal (Valneva 202211– Chief Commercial Officer before GSK) | Chief Commercial Officer (CCO) | Valneva (Group) | Pays de la Loire (region) |
| Pau, Antoine (Truffle Capital 2008– Partner Life Sciences before Mazars + Novartis Pharma) | Partner (venture partner) | Truffle Capital (FR) | Île-de-France (region) |
| Pauchet, Morgan (Holodiag 2006 CSO + co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Holodiag SARL | France (region/state unspecified) |
| Paulsen, Richard (Ipsen 201801– EVP + CEO North America before 10 years at Amgen) | Regional manager | Ipsen (Group) | Île-de-France (region) |
| Paumelle, Jean-François (Eiffel Investment 202103 Partner) | Partner (venture partner) | Eiffel Investment Group (LF) | Île-de-France (region) |
| Pearce, Alexandra (Abivax 201805– VP Regulatory Affairs before Viramal + Glenmark UK + Amgen + Pfizer) | Regulatory Affairs Manager | Abivax (Group) | Île-de-France (region) |
| Pelège, Stéphanie (Lyonbiopole 201312– Communication Manager joined 201212) | Cluster Manager | Lyonbiopôle | Auvergne-Rhône-Alpes (region) |
| Péligry, Luc (Pierre Fabre 201602 Group CFO) | Chief Financial Officer (CFO) | Pierre Fabre (Group) | Île-de-France (region) |
| Pelletier-Bressac, Isabelle (Cellectis 200606 VP BusDev) | Business Development Manager / Strategy Manager | Cellectis (Group) | Île-de-France (region) |
| Peltier, Philippe (Kurma Partners 201709) | Investment Manager | Eurazeo (Group) | Île-de-France (region) |
| Peltier, Sébastien (Valbiotis 201803 Board Chairman) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Valbiotis S.A. (Euronext Growth: ALVAL) | France (region/state unspecified) |
| Pénicaud, Muriel (France (govt) 201601 Head of Business France) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
| Peponnet, Christine (DNA Script 201811– VP Technology Development before CEA + Caliper Biosystems + Genset) | Chief Technology/Technical Officer (CTO) | DNA Script (Group) | Île-de-France (region) |
| Perez, Julien (NewCap. 201509) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Perez, Pascual (Biogemma 200901 CEO) | Chief Executive Officer (CEO) | Biogemma (FR) | Île-de-France (region) |
| Périer, Antoine (Cardinal Systems SAS 201408 CEO) | Chief Executive Officer (CEO) | Venn Life Sciences (Group) | Île-de-France (region) |
| Perles, Léa (Brenus Pharma 202211 Lead Strategic Marketing + External Opportunities before Sanofi) | Sales Manager / Marketing Manager | Brenus Pharma S.A. | Auvergne-Rhône-Alpes (region) |
| Perouse, Alexia (iBionext 201802 Managing Director + Partner before Omnes Capital 201405) | Managing Director | iBionext (Group) | Île-de-France (region) |
| Perraud, Frédéric (Inoviem Scientific 201312– CFO + Polyplus-transfection 201004– COO + Deputy CEO before CEO) | Chief Financial Officer (CFO) | Inoviem Scientific (FR) | Grand Est (Great East) (region) |
| Peslherbe, Christiane (France (govt) 201611 Business France) | Business Development Manager / Strategy Manager | France (govt) | Île-de-France (region) |
| Pessiot, Jérémy (Afyren 202108 Managing Director + CTO + Co-Founder) | Chief Technology/Technical Officer (CTO) | Afyren (Group) | Auvergne-Rhône-Alpes (region) |
| Petersen, Jørgen Søberg (Novo Group 201907 Venture Partner at Novo Ventures) | Venture Partner | Novo Group (Group) | Hovedstaden |
| Petiot, Alessandra (Lauxera 202309 Associate) | Principal (venture capital) | Lauxera (Group) | Île-de-France (region) |
| Petiot, Emmanuel (Deinove 201301– CEO before Director of Sales at Novozymes North America Inc) | Chief Executive Officer (CEO) | Deinove S.A. (Euronext Growth: ALDEI.PA) | Île-de-France (region) |
| Petit, Christine (Institut Pasteur 201905 Professor + Head of Genetics + Physiology of the Hearing Unit) | Professor | Institut Pasteur | Île-de-France (region) |
| Petit, Grégoire (Euronext 201704– Head of Marketing for EU Tech Hub before EY) | Sales Manager / Marketing Manager | Euronext (Group) | Île-de-France (region) |
| Petit, Jean-Michel (IRDI Soridec Gestion 201703 Investment Manager) | Investment Manager | Irdi Soridec Gestion (IRDI Capital Investissement) | Occitanie (Occitania) (region) |
| Petit, Vincent (Metafora Biosystems 201103– President) | President/Director/Head Business Group/Unit/Division | Metafora Biosystems SAS | Île-de-France (region) |
| Peyro-Saint-Paul, Helene (PathoQuest 201610 CMO) | Chief Medical Officer (CMO) | PathoQuest SAS | Île-de-France (region) |
| Peyroles, Alexis (OSE Pharma 201504 CFO) | Chief Financial Officer (CFO) | OSE Immunotherapeutics (Group) | Île-de-France (region) |
| Peyruc, David (Dexstr 201711 CEO + Co-Founder before Sanofi) | Chief Executive Officer (CEO) | Dexstr S.A. | Occitanie (Occitania) (region) |
| Philippe, Édouard (France (govt) 201807 Prime Minister) | Minister | France (govt) | Île-de-France (region) |
| Philippe, Nicolas (SeqOne 202201 CEO + Co-Founder) | Chief Executive Officer (CEO) | SeqOne SAS (SeqOne Genomics) | Occitanie (Occitania) (region) |
| Philips, Mario (Polyplus-transfection, 202011– CEO before PolyNeuros + ArchiMed + Pall Biotech + ATMI Life Sciences) | Chief Executive Officer (CEO) | Sartorius (Group) | Grand Est (Great East) (region) |
| Piat, Stéphane (Carmat 201812 CEO) | Chief Executive Officer (CEO) | Carmat S.A. (ALCAR) | Île-de-France (region) |
| Piazza, Pier Vincenzo (Aelis Farma 201912 CEO + INSERM Neurocentre Magendie Bordeaux) | Chief Executive Officer (CEO) | Aelis Farma S.A. | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Picot, Sylvain (Biom’Up SA 201310 CEO) | Chief Executive Officer (CEO) | Biom’Up S.A. (Euronext: BUP) | Auvergne-Rhône-Alpes (region) |
| Picq, Camille (QPS Netherlands B.V. 201611 Director BusDev Southern Europe) | Business Development Manager / Strategy Manager | QPS (Group) | Groningen (province) |
| Pierrin-Lepinard, Sophie (Banexi Ventures 201204 General Partner Healthcare) | General Partner (venture partner) | Kreaxi (Group) | Île-de-France (region) |
| Pieters, John (201209 former CEO of Amgen France) | Chief Executive Officer (CEO) | Amgen (Group) | California (federal state) |
| Pillot, Martine (BioCellChallenge SAS 201511 Managing Director) | Managing Director | BioCellChallenge SAS (BCC) | France (region/state unspecified) |
| Piot, Stanislas (Stentys 201303 CFO) | Chief Financial Officer (CFO) | SparingVision SAS | Île-de-France (region) |
| Placet, Christine (Horama 2016– Managing Director + Investor before Trophos CEO/CFO + France Biotech Board Member) | Chief Executive Officer (CEO) | Coave Therapeutics (Horama S.A.) | Île-de-France (region) |
| Plasson, Fabrice (Amoeba 201601 President + Co-Founder) | President/Director/Head Business Group/Unit/Division | Amoéba (Group) | Auvergne-Rhône-Alpes (region) |
| Pluquet, Alain (bioMérieux 200911– CTO before since 1994 CEA most currentyl CEA LIST) | Chief Technology/Technical Officer (CTO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Poirier, Nicolas (OSE Immunotherapeutics 202210– CEO + CSO before CSO before Effimune + Tcl Pharma) | Chief Executive Officer (CEO) | OSE Immunotherapeutics (Group) | Pays de la Loire (region) |
| Poirot, Laurent (Cellectis 201802 Head of Early Discovery) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Cellectis (Group) | Île-de-France (region) |
| Policard, Christian (Biotech Developpement Conseils 2002 Founder + Cellectis 201106 Board Director) | Board member, non-executive | Biotech Développement Conseils (BDC) | Île-de-France (region) |
| Portejoie, Florence (FP2COM 202210 Alize RP 201507– before ComCorp) | Public Relations Manager / Investor Relations Manager | Alize RP (Public Relations) | Île-de-France (region) |
| Porter, Richard (Corlieve 201911– CEO + Co-Founder before Therachon + Roche + Shire + Vernalis + Astra) | Chief Executive Officer (CEO) | Corlieve Therapeutics SAS | Île-de-France (region) |
| Pouget, Sacha (BiotechBourse.fr) | n. a. | BiotechBourse.fr – Sacha Pouget (Biotech Bourse) | Île-de-France (region) |
| Poulard, Claire (Omnes Capital 201807 Associate) | Principal (venture capital) | Omnes Capital SAS | Île-de-France (region) |
| Pouletty, Philippe (Truffle Capital 201508 General Partner + Deinove Chairman) | General Partner (venture partner) | Truffle Capital (FR) | Île-de-France (region) |
| Pozzi, Paola (Sofinnova 202005 Partner at Sofinnova Partners) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Prel, Nadége (Affilogic 201508 Director Marketing + Business Development) | Sales Manager / Marketing Manager | Affilogic SAS | Pays de la Loire (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
